| Home | E-Submission | Sitemap | Contact Us |  
top_img
Environ Health Toxicol > Volume 34:2019 > Article
Park, Lee, and Park: Eye irritation tests of polyhexamethylene guanidine phosphate (PHMG) and chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) using a tissue model of reconstructed human cornea-like epithelium

Abstract

Disinfectants including polyhexamethylene guanidine phosphate (PHMG) and mixtures of chloromethylisothiazolinone/ methylisothiazolinone (CMIT/MIT) have been widely used in Korea to prevent microbial growth in the humidifier water, which triggered an outbreak of serious respiratory diseases. In addition to the respiratory syndrome, disease-related symptoms including liver toxicity, asthma, and skin allergies were also found after extensive survey of people exposed to the humidifier disinfectants (HDs). In this study, eye irritation tests were performed based on the Organization for economic co-operation and development (OECD) test guidelines 492 using EpiOcularTM which is a tissue model of reconstructed human cornea-like epithelium. As results, the raw materials of PHMG (26% as active ingredient) and CMIT/MIT (1.5% as active ingredient) were classified under UN globally harmonized system of classification and labeling of chemical (GHS) category 1 or category 2. However, aqueous dilutions of raw materials such as market products of HDs that contain 0.13% of PHMG and 0.03% of CMIT/MIT or further dilutions of the market products for humidifier that contain 0.0013% of PHMG and 0.0003% of CMIT/MIT were classified under any category, which suggested absence of eye irritation at the test concentration.

INTRODUCTION

In April 2011, clinicians at major hospitals in Korea reported a few cases of atypical lung injury among young pregnant women. A series of case studies revealed that the use of humidifier disinfectants (HDs) including polyhexamethylene guanidine phosphate (PHMG) was significantly associated with the development of serious lung injury [1,2,3]. The disinfectants were known to be introduced into consumer markets since 1994, and their use was rapidly increased over the years until the risk was known to the people. Based on a survey of the use of HDs, up to 30% of the entire Korean population seemed to be exposed to chemicals between 2006 and 2011 [4]. According to an online survey of the HDs exposure, the range of HDs usage was an estimated 3.5 to 4.0 million, and about 56% of the total responders were diagnosed with respiratory diseases [5]. Health conditions manifested by the responders exposed to HDs included asthma, pneumonia, bronchitis, rhinitis, atopic dermatitis, headaches, eye disease, kidney ailments, liver disease and others. According to the report, a significant dose-response relationship was observed between the duration of daily exposure and heath condition prevalence [6]. However, many symptoms have not been corroborated based on epidemiological evidence or toxicological tests except for a few cases involving lung fibrosis.
Many studies have suggested that HDs, particularly PHMG and CMIT/MIT mixtures, are associated with diffuse pulmonary fibrosis [7]. Seven-week-old male Sprague-Dawley rats exposed to PHMG aerosol particles for 3 weeks showed pulmonary inflammation and fibrosis including increased levels of inflammatory cytokines and fibronectin mRNA, as well as histopathological changes [8]. PHMG exposure induced immune cell infiltration and significant collagen deposition in the peri-bronchiolar and interstitial areas of lungs. It also induced fibroblast proliferation, and hyperplasia of type II epithelial cells in mice treated for 3 weeks via intratracheal instillation [9]. Intratracheal instillation of PHMG to C57BL/7 mice (1.2 mg/kg) significantly increased the number of neutrophils in the Bronchoalveolar lavage fluid (BALF). Histopathological analysis showed inflammatory cell infiltration and fibrosis in the terminal bronchioles and alveoli in the lungs of PHMG-treated mice [10]. A few epidemiological studies exploring the possible incidence of lung disease caused by CMIT/MIT also showed peripheral airway dysfunction in children. Limited data suggested that patients exposed to HDs containing only CMIT or MIT showed lung injuries clinically similar to those exposed to PHMG [11,12].
Many epidemiological and toxicological studies investigating lung diseases triggered by HDs are now underway. However, few studies have investigated the potential damage to other target organs such as central nervous system, liver, kidney, blood, heart, and skin. Eyes appear to be the direct target of HDs; however, no epidemiological survey of eye diseases or toxicological testing has ever been conducted. In this study, eye irritation tests based on the OECD Test guidelines (TG) 492 were performed using reconstructed human cornea-like epithelium EpiOcularTM, to investigate the potential risk of HDs [13,14].

MATERIALS AND METHODS

Materials

Polyhexamethylene guanidine phosphate (PHMG) was provided by Dr. K. Lee of Korea institute toxicology (Daejeon, Korea). The active ingredient was known to be 26%. The stock solution was used for the preparation of HDs consumer product. CMIT/MIT, which is also known as KathonTM CG and produced by Dow Chemicals, was purchased from the supplier. The active ingredients of KathonTM CG include 5-chloro-2-methyl-4-isothiazolin-3-one (1.15%) and 2-methyl-4-isothiazolin-3-one (0.35%), present in the total aqueous mixture (1.5%) of CMIT/MIT. Magnesium nitrate and magnesium chloride salts were added as inert ingredients up to 23% by weight.
Proficiency testing for technical reliability was performed using chemicals purchased from Sigma-Aldrich (St. Louis, MO, USA). Reconstructed human Cornea-like Epithelium, EpiOcularTM OCL-200 kit, was ordered from MatTek Corporation (Ashland, MA, USA).

Preparation of test chemicals and exposure concentration

According to the supplier’s protocol and OECD TG 492 liquid chemicals should be applied to the EpiOcularTM in volumes of 50 μL per tissue, and solid chemicals up to 50 mg by weight [13,14]. Sterile deionized water was used as a negative control and methyl acetate was used as the positive control. The volumes of both the negative and the positive controls were similar (50 μL). The active ingredients of HDs were tested in three different cases. In the first case, raw materials were used. The concentrations of the active ingredient in the raw materials were 26% (260,000 ppm) of PHMG and 1.5% (15,000 ppm) of CMIT/MIT, respectively. In the second case, the market products which is the diluted formulation were used and the concentration of PHMG was 1,300 ppm. That of CMIT/MIT was 300 ppm. In the last case, assuming the use of concentrations in the humidifier water, 13 ppm of PHMG and 3 ppm of CMIT/ MIT mixture were used. Based on the protocol, the volume of disinfectants applied to EpiOcularTM tissue was also 50 μL.

The EpiOcularTM assay

The EpiOcularTM eye irritation test (OCL-200-EIT) was performed based on the protocol provided by the supplier, MatTek and OECD test guideline 492 [13,14]. On the day of receipt, the tissue was equilibrated to room temperature in its 24-well shipping container for about 15 min. Appropriate volume of medium was pre-warmed to 37˚C and 1 mL was aliquoted into the wells of pre-labeled 6-well plates. The EpiOcularTM tissues were carefully transferred from the 24-well shipping container to the 6-well plates, and pre-incubated for 1 h in a CO2 incubator.
The culture media comprising Dulbecco’s modified eagle’s medium (DMEM) were replaced with a fresh medium and the tissues were incubated for an additional 16 h. Test materials including proficiency testing chemicals were applied to the surface of the cornea tissue model at a volume of either 50 μL by liquid for 30 min or by weight of 50 mg by solid for 6 h in duplicate, respectively. Methyl acetate 50 μL was added to the positive control wells and sterile deionized water 50 μL was used in the negative control wells. The tissues were washed 3 times with 100 mL of Ca2+ Mg2+ free Dulbecco’s phosphate buffered saline (D-PBS). Post-exposure immersion was performed at room temperature in culture media for 12 min in case of liquid chemicals, and for 25 min in case of solid chemicals, respectively. The tissues were transferred to fresh culture media followed by post-exposure incubation for 2 h and 18 h, using liquid and solid chemicals, respectively. The cell viability test was evaluated by MTT assay [15,16].

Classification of eye irritation

Chemicals are identified as “not requiring classification and labeling” according to UN globally harmonized system of classification and labeling of chemical (GHS) if the mean percent tissue viability after exposure and post-exposure incubation is greater than the established cut-off value (60%) for tissue viability. In this case, no further testing by additional methods was required [13,14]. If the mean tissue viability is less than or equal to 60%, it was classified as UN GHS category 1 or 2 according to the 2015 version of the OECD TG 492 guideline. However, the “category 1 or 2” classification was changed to “no prediction can be made” in the revised and adopted version of OECD TG 492 [14]. In this case, further testing with other test methods will be required because EpiOcularTM test methods show a certain number of false positive results. The result of “no prediction can be made” would require additional information for classification purposes. Details are described in OECD TG 492 [13,14].

RESULTS

Proficiency and reliability

Prior to the routine use of EpiOcularTM tests for regulatory purposes, a laboratory should demonstrate its technical proficiency via accurate prediction of the proficiency chemicals. Fifteen chemicals were used in the proficiency test in OECD TG 492 adopted in 2015; however, a few of these chemicals were replaced in the revised version of OECD TG 492 [14]. Table 1 lists the chemical name, CAS number, physical state and viability of the proficiency chemicals. According to the protocol provided by the EpiOcularTM supplier, 5 to 10 proficiency chemicals among those listed in OECD TG, were sufficient for testing and the results of test laboratory need to be harmonized with those of OECD TG 492. In this study, five chemicals including sodium oxalate were selected and tested. The results are shown in Table 2. Results of viability and classification of the chemicals used in this study were fully harmonious with those of OECD TG 492, which guaranteed the reliability and technical proficiency in our laboratory.

EpiOcularTM test of the active ingredients in humidifier disinfectants

The active ingredients in the HDs, including both PHMG and CMIT/MIT decreased cell viability to less than 60% when applied to reconstructed cornea-like epithelium similar to the raw material concentrations. The concentration in raw material was known to be 26% in case of PHMG and 1.5% in case of CMIT/MIT, equal to 260,000 ppm and 15,000 ppm, respectively. Generally, the raw materials were diluted to obtain consumer products of HDs and the specified concentrations were 1,300 ppm (PHMG) and 300 ppm (CMIT/MIT), respectively. Consumers may use the market product by 100–300-fold dilution for humidifier, based on the specification. According to the patterns of usage surveyed by Park et al., the concentration for the worst case of use appeared to be 13 ppm of PHMG and 3 ppm of CMIT/MIT [17].
The viability of methyl acetate as a positive control substance was 42.7±11.5% and that of negative control was 100.0±5.2% (Table 3), which suggests adequate performance of the test system. The viability and classification of the three different concentrations of HDs (raw materials, consumer market products and used concentration in humidifier) are also shown in Table 3. Cell viability was significantly decreased with the raw material concentrations: 40.4±11.0% with PHMG and 3.7± 1.0% with CMIT/MIT. The classifications were “category 1 or 2”. However, cell viability was not decreased under the concentrations specified for consumer market products and humidifier water box. They were classified under “no category”, which suggests no irritation.

DISCUSSION

The Draize rabbit eye test was developed for the identification and evaluation of toxic reactions when the eyes were exposed to the test materials [18]. It was originally used to evaluate the safety of cosmetics and was further extended to evaluate the safe use of insecticides, sun screens and antiseptics [19]. In the test, changes in cornea, conjunctiva, and iris in the rabbit eye served as the endpoints of toxicity. However, the test has been criticized due to the large variation in the test results and the species differences between human and rabbit [20]. Moreover, this test inflicts severe pain on the rabbit during the test procedure. Alternative methods have been developed to reduce the suffering of animals from test chemicals [21].
Among the alternative methods, the short time exposure in vitro test was developed by OECD to identify chemicals inducing serious eye damage using cultured Statens serum institute rabbit cornea (SIRC) cells [22]. In the method, the classification depended on the cell viability at chemical concentrations of 5% and 0.05%. When cell viability was 70% and less at both test concentrations (5% and 0.05%), the chemical is classified as “category 1”, which indicates serious eye damage. Another alternative method developed by OECD is based on Reconstructed human cornea-like epithelium (RhCE), which is used to identify chemicals not requiring classification or labeling for eye irritation of serious eye damage [14]. In this method, three different types of RhCE were introduced, along with their own protocols including the number of tissue replicates, treatment doses and application, exposure time and temperature, etc.
In this study, RhCE of EpiOcularTM was used for PHMG and CMIT/MIT. The standard materials for proficiency test included 15 chemicals listed in OECD TG 492 as shown in Table 1, while 5 chemicals were adequate based on the protocols of EpiOcularTM supplier, MatTek Corporation [13,23].
As shown in Table 2, the proficiency test results were in harmony with that of OECD TG 492 [13]. Although additional chemicals were listed in OECD TG 492 than in the EpiOcularTM supplier’s protocol, they were adequate to guarantee the technical proficiency of laboratory testing and the reliability of data generated in this study. The classification of the chemicals tested in this study was identical to the classification suggested by OECD TG 492 [13]. In addition to the proficiency test, the reliability of EpiOcularTM test in this study was also confirmed by the positive and negative control substances, respectively. As shown in Table 3, the viability in the tissues treated with negative control was 100±5.2%, which was classified under “no category” and the viability of the tissues treated with methyl acetate as positive control was 42.7±11.5%. The viability of methyl acetate-treated tissue was less than 50%, which was the cut-off value of the positive standard. The classification of methyl acetate was “category 1 or 2” as of 2015 version and “no prediction can be made” as of 2018a version, which is harmonious with the classification provided in the OECD TG 492 [13,14]. The final classification of test substances PHMG and CMIT/MIT differed with the concentration. As shown in Table 3, only the raw material showed decreased cell viability and classified under “category 1 or 2”. Both PHMG and CMIT/MIT showed similar concentration dependency, which suggested that the aqueous dilutions of the raw materials were not eye irritants, and therefore, classified under the “no category”.
The exposure concentration in the water of humidifier box was an important parameter determining the risk of eye irritation for the general consumers. The actual exposure concentration for the consumer was estimated by Park et al. [17]. After surveying the concentrations of active ingredient in the commercially available products and their use pattern, the authors suggested the use of 1/100 product dilution in humidifier based on the worst case of exposure scenario. In this study, the cell viability of RhCE tissue was decreased only in tissues treated with raw materials; however, no evidence of cytotoxicity was found in tissues treated with other aqueous dilutions in market products and in the humidifier water box. The classification of “no prediction can be made” in the revised version of OECD TG 492 may suggest that the test chemicals cannot be evaluated using this test system and further testing based on other in vitro test guidelines is required [14]. The revised version of 2018a appears to replace the conclusions described in the original version of 2015 OECD TG 492, because of the highly confirmative category 1 or 2. In contrast to category 1 or 2, chemicals do not require classification or labeling in the no category.
The Draize test using albino rabbits showed that CMIT/MIT 1.5% (15,000 ppm, as active ingredients) was corrosive when tested as supplied, which is highly consistent with the EpiOcularTM test results in this study [24]. However, the aqueous dilution of CMIT/MIT at concentrations of 0.056% (560 ppm, as active ingredient) was nonirritating and 0.28% (2800 ppm) showed slight to moderate irritation [24]. The results seem to be consistent with our EpiOcularTM test. As shown in Table 3, CMIT/MIT 300 ppm was classified under “no category”, suggesting lack of irritation.
In addition to eyes, CMIT/MIT induces skin irritation in rabbits and the results were similar to those of eyes [24]. As far as we know, no data pertaining to the eye or skin irritation of PHMG are available.
In summary, the raw materials of PHMG and CMIT/MIT were classified under “category 1 (serious eye damage) or category 2 (eye irritation)”. The classification was replaced by “no prediction can be made” in the revised OECD TG 492, which indicates that it is not a definitive eye irritant. Further testing with other test methods will be required [14]. Aqueous dilutions of raw material found in market products or in the humidifier were classified under the “no category” in this study, which do not meet the criteria for serious eye damage or irritation.

ACKNOWLEDGEMENTS

This study was supported by the Korea ministry of environment (MOE) through the environmental health action program (2017001360001).

CONFLICT OF INTEREST

The authors have no conflicts of interest associated with this study to disclose.

References

1. Korea Centers for Disease Control and Prevention (KCDC). Interim report of epidemiologic investigation of lung injury with unknown causes in Korea Korean]. Public Health Weekly Report 2011a;817-818.

2. Korea Centers for Disease Control and Prevention (KCDC). Hospital based case-control study of lung injury with unknown causes Korea]. Public Health Weekly Report 2011b;817-818.

3. Kim S, Paek D. Humidifier disinfectant disaster: what is known and what needs to be clarified. Environ Health Toxicol 2016;31: e2016025.
crossref pmid pdf
4. Paek D, Koh Y, Park DU, Cheong HK, Do KH, Lim CM, et al. Nationwide study of humidifier disinfectant lung injury in South Korea, 1994- 2011. Incidence and dose-response relationships. Ann Am Thorac Soc 2015;12(12):1813-1821.
crossref pmid
5. Leem JH, Kim HJ, Cheong HK, Lee KM, Lee JH, Park KS, et al. Final report: selection and diagnostic criteria for non-lung diseases according to the use of humidifier disinfectant. Seoul: Korean Society of Environmental Health and Toxicology; 2017. p. 13-83.

6. Leem JH, Lee JH. Humidifier disinfectant-associated specific diseases should be called together as “humidifier disinfectant syndrome”. Environ Health Toxicol 2017;32: e2017017.
crossref pmid pmc pdf
7. Park DU, Ryu SH, Lim HK, Kim SK, Choi YY, Ahn JJ, et al. Types of household humidifier disinfectant and associated risk of lung injury (HDLI) in South Korea. Sci Total Environ 2017;597: 53-60.
crossref
8. Kim HR, Lee K, Park CW, Song JA, Shin DY, Park YJ, et al. Polyhexamethylene guanidine phosphate aerosol particles induce pulmonary inflammatory and fibrotic responses. Arch Toxicol 2016;90(3):617-32.
crossref pmid pdf
9. Song J, Kim W, Kim YB, Kim B, Lee K. Time course of polyhexamethyleneguanidine phosphate-induced lung inflammation and fibrosis in mice. Toxicol Appl Pharmacol 2018;345: 94-102.
crossref pmid
10. Kim MS, Kim SH, Jeon D, Kim HY, Lee K. Changes in expression of cytokines in polyhexamethylene guanidine-induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis. Toxicology 2018;393: 185-192.
crossref pmid
11. Cho HJ, Park DU, Yoon J, Lee E, Yang SI, Kim YH, et al. Effects of a mixture of chloromethylisothiazolinone and methylisothiazolinone on peripheral airway dysfunction in children. PLoS One 2017;12(4):e0176083.
crossref pmid pmc
12. Lee E, Son SK, Yoon J, Cho HJ, Yang SI, Jung S, et al. Two Cases of Chloromethylisothiazolinone and Methylisothiazolinone-associated Toxic Lung Injury. J Korean Med Sci 2018;33(16):e119.
crossref pmid pmc
13. OECD. Test Guideline 492; Reconstructed human cornea-like epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. 2015.

14. OECD. Test Guideline 492; Reconstructed human cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation or serious eye damage. 2018a.

15. Settivari RS, Amado RA, Corvaro M, Visconti NR, Kan L, Carney EW, et al. Tiered application of the neutral red release and EpiOcular™ assays for evaluating the eye irritation potential of agrochemical formulations. Regul Toxicol Pharmacol 2016;81: 407-420.
crossref pmid
16. Kandarova H, Letasiova S, Adriaens E, Guest R, Willoughby JAS, Drzewiecka A, et al. CON4EI: CONsortium for in vitro Eye Irritation testing strategy-EpiOcularTM time-to-toxicity (EpiOcular ET-50) protocols for hazard identification and labelling of eye irritating chemicals. Toxicol In Vitro 2018;49: 34-52.
crossref pmid
17. Park DU, Ryu SH, Lim HK, Kim SK, Roh HS, Cha WS, et al. Estimation of humidifier disinfectant amounts inhaled into the respiratory system. J Environ Health Sci 2016;42(3):141-146.
crossref pdf
18. Draize JH, Woodard G, Calvery HO. Methodsfor the study of irritation and toxicity of substances appliedtopically to the skin and mucous membranes. J Pharmacol Exp Ther 1944;82: 377-390.

19. Fitzhugh O, Woodard G. The toxicities of compounds related to 2,3-dimercaptopropanol (BAL) with a note on their relative therapeutic efficiency. J Pharmacol Exp Ther 1946;87: 23-27.
pmid
20. Freeberg F, Nixon G, Reer P, Weaver J, Bruce R, Griffith J, et al. Human and rabbit eye responses to chemical insult. Toxicol Sci 1986;7: 626-634.
crossref pdf
21. Lee M, Hwang JH, Lim KM. Alternatives to In Vivo Draize rabbit eye and skin Irritation tests with a focus on 3D reconstructed human cornea-like epithelium and epidermis models. Toxicol Res 2017;33(3):191-203.
crossref pmid pmc pdf
22. OECD. Test Guideline 491; Short time exposure In vitro test method for identifying i) Chemicals inducing serious eye damage and ii) Chemicals not requiring classification for eye irritation or serious eye damage. 2018b.

23. MatTeK. EpiOcular™ Eye Irritation Test (OCL-200-EIT) For the prediction of acute ocular irritation of chemicals for use with MatTek Corporation’s Reconstructed Human EpiOcularTM Model. 2015. https://www.mattek.com/.../EpiOcular-Eye-Irritation-Test-EIT.pdf.

24. Burnett CL. 6 Final report on the safety assessment of methylisothiazolinone and methylchloroisothiazolinone. Int J Toxicol 1992;11(1):75-128.

Table 1.
Proficiency test substances listed in 2015 version of OECD TG 492
Classification Chemical name CAS No. Physical state Viability (%) Classification
In vivo category 1 Methylthioglycolate 2365-48-2 liquid 10.9 ± 6.4 cat 2 / cat 1
Tetraethylene glycol diacrylate 17831-71-9 liquid 34.9 ± 15.3 cat 2 / cat 1
2,5-Dimethyl-2,5-hexanediol 110-03-2 solid 2.3 ± 0.2 cat 2 / cat 1
Sodium oxalate 62-76-0 solid 29.0 ± 1.2 cat 2 / cat 1
In vivo category 2A 2,4,11,13-Tetraazatetradecane-diimidamide, N,N''-bis(4-chlorophenyl)-3,12-diimino-, di-D-gluconate (20%, aqueous) 18472-51-0 liquid 4.0 ± 1.1 cat 2 / cat 1
1,5-Naphthalenediol 83-56-7 solid 21.0 ± 7.4 cat 2 / cat 1
In vivo category 2B Diethyl toluamide 134-62-3 liquid 15.6 ± 6.3 cat 2 / cat 1
2,2-Dimehtly-3-methylenebicyclo [2.2.1] heptane 79-92-5 solid 4.7 ± 1.5 cat 2 / cat 1
In vivo no category 1-Ethyl-3-methylimidazolium ethylsulphate 342573-75-5 liquid 79.9 ± 6.4 no cat
Dipropyl disulphide 629-19-6 liquid 81.7 ± 6.4 no cat
Piperonyl butoxide 1951-03-06 liquid 104.2 ± 4.2 no cat
Polyethylene glycol (PEG-40) hydrogenated castor oil 61788-85-0 viscous 77.6 ± 5.4 no cat
1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl) urea 101-20-2 aolid 106.7 ± 5.3 no cat
2,2'-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol) 103597-45-1 aolid 102.7 ± 13.4 no cat
Potassium tetrafluoroborate 14075-53-7 aolid 88.6 ± 3.3 no cat
Table 2.
Results of proficiency testing for eye irritation based on the OECD TG 492
Chemical name Cell viability (%) Difference of viability (%) Classification
Classification in OECD TG492 Results in this study
1-Ethyl-3-methylimidazolium ethylsulphate 90.3 8.0 no cat no cat
Dipropyl disulphide 83.0 9.5 no cat no cat
Piperonyl butoxide 102.1 5.6 no cat no cat
2,5-Dimethyl-2,5-hexanediol 1.3 0.5 cat 2 / cat 1 cat 2 / cat 1
Sodium oxalate 14.8 2.8 cat 2 / cat 1 cat 2 / cat 1
Table 3.
Results of EipOcular™ assay for the humidifier disinfectants
Substance Viability (%) (Mean ± S.D.*) Results of classification**
Negative control 100.0 ± 5.2 no cat
Positive control (Methyl acetate) 42.7 ± 11.5 cat 2 / cat 1
PHMG in raw material (260,000 ppm) 40.4 ± 11.0 cat 2 / at 1
in market product (1,300 ppm) 102.9 ± 15.9 no cat
in humidifier (13 ppm) 106.8 ± 17.2 no cat
CMIT/MIT in raw material (15,000 ppm) 3.7 ± 1.0 cat 2 / cat 1
in market product (300 ppm) 105.7 ± 14.6 no cat
in humidifier (3 ppm) 108.9 ± 10.1 no cat

* This results were obtained by performing each 3 independent runs.

** Classification was performed by OECD TG 492 adopted in 2015. In the revised version of 2018 TG,

“cat 2 / cat 1” was replaced by “no prediction can be made”.

Editorial Office
Division of Environmental Science and Ecological Engineering Korea University
145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea
Tel : +82-2-740-8328   Fax : +82-2-764-8328   E-mail: envitoxic@gmail.com
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © 2019 by The Korean Society of Environmental Health and Toxicology/Korea Society for Environmental Analysis. All rights reserved.     powerd by m2community